ES2144126T3 - Composicion que comprende un plasmido recombinante y sus utilizaciones como vacuna y medicamento. - Google Patents

Composicion que comprende un plasmido recombinante y sus utilizaciones como vacuna y medicamento.

Info

Publication number
ES2144126T3
ES2144126T3 ES95914392T ES95914392T ES2144126T3 ES 2144126 T3 ES2144126 T3 ES 2144126T3 ES 95914392 T ES95914392 T ES 95914392T ES 95914392 T ES95914392 T ES 95914392T ES 2144126 T3 ES2144126 T3 ES 2144126T3
Authority
ES
Spain
Prior art keywords
composition
pct
recombinant plasmid
vaccine
medication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95914392T
Other languages
English (en)
Inventor
Vincent Ganne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Original Assignee
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA filed Critical Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Application granted granted Critical
Publication of ES2144126T3 publication Critical patent/ES2144126T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

COMPOSICION QUE CONTIENE UN PLASMIDO RECOMBINANTE QUE COMPRENDE UNA SECUENCIA NUCLEOTIDICA EXOGENA CAPAZ DE EXPRESAR EN UN ORGANISMO HUESPED UN COMPUESTO QUE COMPRENDE UNA SECUENCIA DE AMINOACIDOS, COMPRENDIENDO DICHA COMPOSICION UNA EMULSION QUE LLEVA AL MENOS UNA FASE ACUOSA Y AL MENOS UNA FASE E ACEITE, ESTANDO ESTE PLASMIDO RECOMBINANTE CONTENIDO EN UNA AL MENOS DE DICHAS FASES. LA INVENCION SE REFIERE TAMBIEN A UNA VACUNA Y A UN MEDICAMENTO CURATIVO QUE COMPRENDE DICHA COMPOSICION.
ES95914392T 1994-03-22 1995-03-21 Composicion que comprende un plasmido recombinante y sus utilizaciones como vacuna y medicamento. Expired - Lifetime ES2144126T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9403361A FR2717694B1 (fr) 1994-03-22 1994-03-22 Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et médicament.

Publications (1)

Publication Number Publication Date
ES2144126T3 true ES2144126T3 (es) 2000-06-01

Family

ID=9461309

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95914392T Expired - Lifetime ES2144126T3 (es) 1994-03-22 1995-03-21 Composicion que comprende un plasmido recombinante y sus utilizaciones como vacuna y medicamento.

Country Status (8)

Country Link
US (1) US5801157A (es)
EP (1) EP0751788B1 (es)
JP (1) JP3436371B2 (es)
AT (1) ATE188123T1 (es)
DE (1) DE69514217T2 (es)
ES (1) ES2144126T3 (es)
FR (1) FR2717694B1 (es)
WO (1) WO1995025542A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707896B1 (fr) * 1993-07-22 1995-09-01 Chemoxal Sa Procédé de traitement d'un article et nouvelle solution aqueuse de peroxyde d'hydrogène.
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2754715B1 (fr) * 1996-10-18 1998-11-13 Seppic Sa Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant
DE19637043A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Neue Aminoalkoholderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel und Reagenzien
US7097854B2 (en) 1996-09-12 2006-08-29 Medigene Oncology Gmbh Amino alcohol derivatives, process for their production and pharmaceutical preparations and reagents containing these compounds
FR2754182B1 (fr) * 1996-10-07 1998-11-06 Seppic Sa Nouvelles compositions vaccinales comportant comme adjuvant un compose sympathomimetique
GB9626865D0 (en) * 1996-12-24 1997-02-12 Cyanamid Websters Pty Limited Veterinary vaccines
NZ503636A (en) * 1997-10-17 2002-05-31 Fort Dodge Australia Pty Vaccines for the prevention of clostridial diseases of sheep that provide effective immunity for up to a year or more from a single dose
FR2800280B1 (fr) 1999-10-29 2003-09-19 Seppic Sa Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite
FR2814956B1 (fr) * 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
FR2922767B1 (fr) * 2007-10-24 2009-12-18 Seppic Sa Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649012B1 (fr) * 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
FR2700957B1 (fr) * 1993-01-29 1995-03-03 Seppic Sa Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation.

Also Published As

Publication number Publication date
DE69514217T2 (de) 2000-09-07
WO1995025542A1 (fr) 1995-09-28
JPH09510359A (ja) 1997-10-21
ATE188123T1 (de) 2000-01-15
US5801157A (en) 1998-09-01
EP0751788A1 (fr) 1997-01-08
JP3436371B2 (ja) 2003-08-11
DE69514217D1 (de) 2000-02-03
EP0751788B1 (fr) 1999-12-29
FR2717694A1 (fr) 1995-09-29
FR2717694B1 (fr) 1996-05-03

Similar Documents

Publication Publication Date Title
ES2144126T3 (es) Composicion que comprende un plasmido recombinante y sus utilizaciones como vacuna y medicamento.
BR9814276A (pt) Antìgenos de superfìcie
DE69326776T2 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
ATE172636T1 (de) Liposomales verabreichungssystem für biologisch aktive stoffe
BR9809691A (pt) Usos de substâncias de óleo
DE69529748D1 (de) Polynukleotide vakzine gegen den papilloma virus
DE69326250D1 (de) Neuropeptide y antagoniste
ATE85081T1 (de) Analoge des gewebespezifischen plasminogenaktivators.
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
ATE297464T1 (de) Pharmazeutische zusammensetzungen zur therapie der herzinsuffizienz
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
HUT77029A (hu) A GAP-protein SH3 doménjéhez kötődni képes peptidek, ezeket kódoló nukleotidszekvenciák és előállításuk és alkalmazásuk
AUPN154295A0 (en) Nucleic acid molecule encoding a protein with avian gamma-interferon activity
KR970703428A (ko) Hcmv 및 hsv로부터의 융합 당단백질(fusion glycoprotein from hcmv and hsv)
FR2763592B1 (fr) Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant
MY101874A (en) Vaccine
ATE314481T1 (de) Promotor des transaldolase-genes von k.lactis und dessen verwendung
BR0109279A (pt) Antagonistas de lhrh, sua preparação e aplicação como medicamento
ATE245998T1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
DE69332652T2 (de) Verbesserungen in bezug auf die herstellung von malariaimpstoffen
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE60140950D1 (de) Neuer gentherapeutischer wirkstoff zur behandlung g
AR003926A1 (es) Variante de adnasa humana i, ácido nucleico que la codifica, uso de dicha variante para preparar medicamentos útiles en el tratamiento de una enfermedad o afección pulmonar y una composición farmacéutica que contiene dicha variante.
BR9814433A (pt) "beta-lipotropina e usos da mesma"
DE60219601D1 (de) Durch liposome vermittelte dna verabreichung

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 751788

Country of ref document: ES